Evidence map›Paper›PMID 25186244›Full record

ReviewMicrobial cell factories2014

The art of strain improvement of industrial lactic acid bacteria without the use of recombinant DNA technology.

Patrick M F Derkx, Thomas Janzen, Kim I Sørensen, Jeffrey E Christensen, Birgitte Stuer-Lauridsen, Eric Johansen

Abstract readReview
In one paragraph

Review in Microbial cell factories, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Development ofBiotechnology reports (Amsterdam, Netherlands) · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Metabolic behavior for a mutantFrontiers in microbiology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Droplet-Based Microfluidic High Throughput Screening ofFrontiers in bioengineering and biotechnology · 2021
    Article
  16. Conjugative DNA Transfer FromFrontiers in microbiology · 2021
    Article
  17. Enhancement of amino acid production and secretion byMetabolic engineering communications · 2020
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Patrick M F Derkx
Thomas Janzen
Kim I Sørensen
Jeffrey E Christensen
Birgitte Stuer-Lauridsen
Eric Johansen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The food industry is constantly striving to develop new products to fulfil the ever changing demands of consumers and the strict requirements of regulatory agencies. For foods based on microbial fermentation, this pushes the boundaries of microbial performance and requires the constant development of new starter cultures with novel properties. Since the use of ingredients in the food industry is tightly regulated and under close scrutiny by consumers, the use of recombinant DNA technology to improve microbial performance is currently not an option. As a result, the focus for improving strains for microbial fermentation is on classical strain improvement methods. Here we review the use of these techniques to improve the functionality of lactic acid bacteria starter cultures for application in industrial-scale food production. Methods will be described for improving the bacteriophage resistance of specific strains, improving their texture forming ability, increasing their tolerance to stress and modulating both the amount and identity of acids produced during fermentation. In addition, approaches to eliminating undesirable properties will be described. Techniques include random mutagenesis, directed evolution and dominant selection schemes.

Indexed as

Food MicrobiologyGenetic EngineeringBacteriophagesCarbohydrate MetabolismCitric AcidDrug Resistance, BacterialLactobacillusPolysaccharides, BacterialCitric AcidPolysaccharides, Bacterial

Identifiers

PMID25186244
PMCPMC4155822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.